<TEXT>&#2;<DATELINE>2012-04-20</DATELINE><TITLE>Selective Inhibition of USP7</TITLE><BODY>The deubiquitinating enzyme USP7 is an emerging oncology and antiviral target. Reverdy et al., in this issue of Chemistry & Biology, disclose the first small-molecule inhibitor selective for USP7, which recapitulates its knockdown in cancer cells and hence demonstrates the therapeutic feasibility of USP7 inhibitors.&#3;</BODY></TEXT>